Abstract:Background and Objective Type 2 diabetes (T2D)-associated periodontitis is severe and refractory in many cases. Considered an inflammatory disease, T2D predisposes to periodontitis by increasing whole-body inflammation. One mechanism of increased inflammation is thatT2D is mediated by loss of production or function of the anti-inflammatory hormone adiponectin. In our previous report, AdipoRon, an adiponectin receptor agonist, and AdipoAI, a newly discovered, more specific agonist, attenuated T2D-associated inflammation by inhibiting osteoclastogenesis and LPS-induced endotoxemia. Autophagy plays an important role during osteoclast differentiation and function. The impact of AdipoAI on osteoclast function and autophagy involved in osteoclastogenesis is not known. Here, we compare AdipoRon and AdipoAI potency, side effects and mechanism of action in T2D-associated periodontitis. Methods The RAW 264.7 cell line was used for in vitro studies. We analyzed the potential cytotoxicity of AdipoAI using the CCK-8 assay. The anti-osteoclastogenic potential of AdipoAI was studied by real-time qPCR and tartrate-resistant acid phosphatase staining. The actions of AdipoAI involved in autophagy were tested by real-time qPCR, western blot and immunofluorescence staining. In the diet-induced obesity model of T2D, we investigated the impact of AdipoAI on fasting blood glucose, alveolar bone loss, and gingival inflammation in mice with experimental periodontitis. Results AdipoRon inhibited osteoclastogenesis and AdipoAI inhibited osteoclastogenesis at lower doses than AdipoRon without any cytotoxicity. In DIO mice with experimental periodontitis, AdipoAI reduced mouse body weight in 14 days, reducing fasting glucose levels, alveolar bone destruction, osteoclast number along the alveolar bone surface, and decreased the expression of pro-inflammatory factors in periodontal tissues. AdipoAI and AdipoRon also enhanced LC3A/B expression when cultured with RANKL.3-Methyladenine, a known autophagy inhibitor, decreased LC3A/B expression and reversed the inhibition of osteoclastogenesis during AdipoAI treatment. Conclusions Our results demonstrate that AdipoAI ameliorates the severity of T2D-associated periodontitis by enhancing autophagy in osteoclasts at lower doses than AdipoRon without demonstrable side effects. Thus, AdipoAI has pharmaceutical potential for treating diabetes-associated periodontal disease.

AdipoRon Accelerates Bone Repair of Calvarial Defect in Diet-Induced Obesity Mice

Adiponectin Regulates Bone Marrow Mesenchymal Stem Cell Niche Through a Unique Signal Transduction Pathway: an Approach for Treating Bone Disease in Diabetes

AdipoRon Promotes Diabetic Fracture Repair Through Endochondral Ossification-Based Bone Repair by Enhancing Survival and Differentiation of Chondrocytes

Effect Of Intermittent Administration Of Adiponectin On Bone Regeneration Following Mandibular Osteodistraction In Rabbits

Effect of adiponectin on bone regeneration following rapid mandibular distraction osteogenesis in rabbits

Paracrine Effects of Recombinant Human Adiponectin Promote Bone Regeneration

Exploring the Logic and Conducting a Comprehensive Evaluation of the Adiponectin Receptor Agonists AdipoRon and AdipoAI's Impacts on Bone Metabolism and Repair-A Systematic Review

AdipoRon Protects Against Tubular Injury in Diabetic Nephropathy by Inhibiting Endoplasmic Reticulum Stress

Exploring the Logic and Conducting a Comprehensive Evaluation of the Adiponectin Receptor Agonists AdipoRon and AdipoAI’s Impacts on Bone Metabolism and Repair-A Systematic Review

A Novel Adiponectin Receptor Agonist (adipoai) Ameliorates Type 2 Diabetes-Associated Periodontitis by Enhancing Autophagy in Osteoclasts.

Short-term caloric restriction induced bone loss in both axial and appendicular bones by increasing adiponectin

Adiponectin Receptor Agonist AdipoRon Attenuates Calcification of Osteoarthritis Chondrocytes by Promoting Autophagy

Activating Adiponectin Signaling with Exogenous AdipoRon Reduces Myelin Lipid Accumulation and Suppresses Macrophage Recruitment after Spinal Cord Injury.

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES MARROW

Deficiency Of Adiponectin Protects Against Ovariectomy-Induced Osteoporosis In Mice

Adiponectin overexpression promotes fracture healing through regulating the osteogenesis and adipogenesis balance in osteoporotic mice

Adiponectin receptors agonist alters microbiota to improve implant osseointegration in diabetic mice

The Effect of Local Delivery of Adiponectin from Biodegradable Microsphere-Scaffold Composites on New Bone Formation in Adiponectin Knockout Mice.

Central Adiponectin Administration Reveals New Regulatory Mechanisms of Bone Metabolism in Mice.

An Adiponectin Receptor Agonist Reduces Type 2 Diabetic Periodontitis.

Rhpdgf-Bb Via Erk Pathway Osteogenesis and Adipogenesis Balancing in Adscs for Critical-Sized Calvarial Defect Repair